Probiotics and Antimicrobial Proteins最新文献

筛选
英文 中文
Dietary Clostridium butyricum NCU-02 and Its Postbiotic Butyrate Ameliorate Autism Spectrum Disorder-like Symptoms: Involvement of Hippocampal Oxidative Stress Modulation. 膳食丁酸梭菌NCU-02及其生后丁酸盐改善自闭症谱系障碍样症状:海马氧化应激调节的参与
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-14 DOI: 10.1007/s12602-026-11303-4
Kangtai Zeng, Qiuyu Wu, Liye Wang, Chengrui Liu, Mengqian Li, Tingtao Chen, Jie Luo
{"title":"Dietary Clostridium butyricum NCU-02 and Its Postbiotic Butyrate Ameliorate Autism Spectrum Disorder-like Symptoms: Involvement of Hippocampal Oxidative Stress Modulation.","authors":"Kangtai Zeng, Qiuyu Wu, Liye Wang, Chengrui Liu, Mengqian Li, Tingtao Chen, Jie Luo","doi":"10.1007/s12602-026-11303-4","DOIUrl":"https://doi.org/10.1007/s12602-026-11303-4","url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) is a neurodevelopmental condition closely linked to gut microbiota dysbiosis and gut-brain axis dysfunction, yet effective dietary interventions remain limited. This study evaluated the therapeutic potential of Clostridium butyricum NCU-02, a probiotic candidate, and its sterile supernatant in a valproic acid (VPA)-induced mouse model of ASD, with emphasis on their postbiotic properties. Both treatments significantly ameliorated core ASD-like behaviors, attenuating repetitive marble-burying by over 35% and restoring social novelty preference to near-control levels (p < 0.05 for both). These interventions were associated with improved intestinal barrier integrity, upregulated tight junction proteins (ZO-1 and occludin), and suppressed colonic and hippocampal pro-inflammatory cytokines (IL-1β, IL-6, TNF-α). Metabolomics profiling identified butyrate as a key differential metabolite, with butyrate levels elevated by approximately 1.3- to 2.5-fold following interventions (all p < 0.05 vs. M group). Correlation analyses further linked butyrate elevation to activation of the hippocampal GPR109A/AMPK/Nrf2 pathway and reduction of oxidative stress markers. Collectively, these findings suggest that C. butyricum NCU-02 and its sterile supernatant are associated with protective effects against ASD-like symptoms, and that the postbiotic metabolite butyrate may contribute to these benefits through dual modulation of gut homeostasis and neuroprotective signaling. A sodium-butyrate comparison group reproduced several of these effects, indicating that exogenous butyrate is sufficient to reproduce several of these effects, although the present design does not establish butyrate as a necessary mediator for the live-strain effects. These findings position butyrate, and butyrate-producing probiotics, as promising candidates for dietary intervention in neurodevelopmental disorders.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotic-Mediated Mitigation of Metal(loid)-Induced Toxicity: Mechanisms, Preclinical Evidence, and Clinical Translation. 益生菌介导的减轻金属(样蛋白)诱导的毒性:机制、临床前证据和临床翻译。
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-14 DOI: 10.1007/s12602-026-11289-z
Praburaman Loganathan, Vijayapoopathi Singaravel, Satish Kumar Rajappan Chandra, Kamala-Kannan Seralathan
{"title":"Probiotic-Mediated Mitigation of Metal(loid)-Induced Toxicity: Mechanisms, Preclinical Evidence, and Clinical Translation.","authors":"Praburaman Loganathan, Vijayapoopathi Singaravel, Satish Kumar Rajappan Chandra, Kamala-Kannan Seralathan","doi":"10.1007/s12602-026-11289-z","DOIUrl":"https://doi.org/10.1007/s12602-026-11289-z","url":null,"abstract":"<p><p>Heavy metal(loid)s contamination remains a major environmental and public health concern because toxic metal(loid)s such as lead, cadmium, mercury, arsenic, and chromium are persistent, non-biodegradable, and bioaccumulative. Chronic exposure disrupts cellular homeostasis through oxidative stress, enzyme inhibition, genotoxicity, inflammatory signalling, and gut microbiota dysbiosis, thereby contributing to multi organ injury and chronic disease. Conventional detoxification approaches, particularly chelation therapy, are constrained by limited specificity, adverse effects, and poor suitability for long-term low-dose exposure. In this context, probiotics have emerged as promising biological agents for mitigating metal(loid)s-induced toxicity. This review summarises current evidence from mechanistic studies, in vitro experiments, animal models, and human trials regarding the protective role of probiotics against metal(loid)s toxicity. Probiotics reduce metal(loid)s bioavailability through biosorption, bioaccumulation, and biotransformation, while also strengthening intestinal barrier integrity, restoring microbial balance, suppressing inflammation, and enhancing antioxidant defence pathways, especially Nrf2-mediated responses. Selected preclinical studies report reductions in tissue metal(loid) accumulation and attenuation of oxidative, inflammatory, and histopathological injury; however, these effects are strain- and exposure-dependent, and the limited human evidence does not establish consistent clinical detoxification efficacy. Nevertheless, clinical translation remains limited by strain-specific variability, non-standardised dosing, inter-individual heterogeneity, and the scarcity of large-scale randomised trials. Overall, selected probiotic strains show potential as adjunct interventions for mitigating metal(loid)-associated toxicity; however, their clinical efficacy, strain-specific safety, optimal dosing, and long-term tolerability remain insufficiently established, particularly in vulnerable populations. Rigorous clinical evaluation is therefore essential before therapeutic or preventive implementation.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Lactiplantibacillus plantarum 299v on Irritable Bowel Syndrome: A Systematic Review with Meta-analysis. 植物乳杆菌299v对肠易激综合征的影响:一项meta分析的系统综述
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-14 DOI: 10.1007/s12602-026-11296-0
Viviana Fara Brindicci, Vanessa Nadia Dargenio, Giovanni La Grasta, Stefania Paola Castellaneta, Federico Schettini, Ruggiero Francavilla, Fernanda Cristofori
{"title":"The Effects of Lactiplantibacillus plantarum 299v on Irritable Bowel Syndrome: A Systematic Review with Meta-analysis.","authors":"Viviana Fara Brindicci, Vanessa Nadia Dargenio, Giovanni La Grasta, Stefania Paola Castellaneta, Federico Schettini, Ruggiero Francavilla, Fernanda Cristofori","doi":"10.1007/s12602-026-11296-0","DOIUrl":"https://doi.org/10.1007/s12602-026-11296-0","url":null,"abstract":"<p><p>Lactiplantibacillus (L.) plantarum 299​v DSM 9843 is a probiotic strain that showed safety and properties potentially beneficial in managing irritable bowel syndrome (IBS). To systematically review and meta-analyze the effects of L. plantarum 299​v in participants of randomized controlled trials (RCTs) with IBS. We searched PubMed/MEDLINE, Embase, Scopus, and the Cochrane Central Register of Controlled Trials. A meta-analysis was performed using a random-effects model, pooling the outcomes of abdominal pain, bloating/flatulence, constipation, global symptoms. The review protocol was registered in PROSPERO (registration number CRD420261322875). Six RCTs enrolling 527 adult patients with IBS were included. L. plantarum 299​v significantly reduced abdominal pain scores (SMD = - 2.16; 95% CI - 3.59 to - 0.72; p = 0.003), abdominal pain severity (SMD = - 0.39; 95% CI​ - 0.67 to - 0.12; p = 0.005), daily abdominal pain frequency (SMD = - 0.66; 95% CI​ - 1.02 to - 0.30; p = 0.0004) compared with placebo. The improvement rates of abdominal pain (RR = 4.83; 95% CI​ 1.94-11.99; p = 0.0007), bloating/flatulence (RR = 1.96; 95% CI​ 1.06-3.61; p = 0.03) and global symptoms (RR = 4.69; 95% CI​ 1.52-14.45; p = 0.007) were significantly higher in the probiotic group. No significant effect was observed for constipation (RR = 1.39; 95% CI 0.32-6.11; p = 0.66). Meta-analytic evidence supports the capacity of L. plantarum 299​v to relieve abdominal pain, bloating, flatulence, and general symptoms. The observed diet-dependent response underscores the need for future research to investigate combined probiotic dietary interventions.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Application of Engineered Probiotics in the Prophylaxis and Control of Salmonella Infections. 工程益生菌在预防和控制沙门氏菌感染中的应用
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-13 DOI: 10.1007/s12602-026-11288-0
Zhihan Zhu, Fuzhou Xu, Daifei Yin, Yuxin Shao
{"title":"The Application of Engineered Probiotics in the Prophylaxis and Control of Salmonella Infections.","authors":"Zhihan Zhu, Fuzhou Xu, Daifei Yin, Yuxin Shao","doi":"10.1007/s12602-026-11288-0","DOIUrl":"https://doi.org/10.1007/s12602-026-11288-0","url":null,"abstract":"<p><p>Salmonella is a major zoonotic pathogen responsible for human and animal infections, posing significant challenges to public health and disease control. Its pathogenicity relies on a suite of molecular mechanisms mediating bacterial adhesion, invasion, intracellular persistence, immune evasion, and host-microbe crosstalk. Conventional probiotics mitigate Salmonella infection through competitive exclusion, secretion of antimicrobial metabolites, intestinal barrier reinforcement, microbiota remodelling and host immunomodulation. However, their efficacy varies depending on strain, host, dose, formulation, delivery route, infection model, and intervention timing. Genetically engineered probiotics and complementary non-genetic functional enhancement strategies offer opportunities to introduce or tailor defined antimicrobial, biosensing, colonisation or ecological functions. This narrative review summarizes recent progress in genetically engineered probiotics, non-genetic functional enhancement of probiotics, and attenuated pathogen strains for Salmonella control. Genetically engineered probiotics are equipped with programmable regulatory and antibacterial modules, while non-genetic probiotic approaches include probiotic-nanomaterial biohybrids, metabolically adapted strains and microbiome-directed substrate interventions. Preclinical studies show these microbial systems can provide programmable, targeted, context-dependent functions to reduce Salmonella colonisation, though their performance is also highly context-dependent. Future studies should focus on improving functional stability, standardizing efficacy and biosafety evaluation, clarifying ecological and environmental risks, and addressing manufacturing, formulation, quality-control, and regulatory requirements for translational development.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Environmental Microbiomes as Sources of Postbiotic Therapeutics: A One Health Perspective on Translational Applications. 环境微生物组作为生物后治疗的来源:从一个健康角度看转化应用。
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-13 DOI: 10.1007/s12602-026-11293-3
Victor Uchenna Chigozie, Eddison Igho Oghonyon, Emmanuel Okoro Enyi
{"title":"Environmental Microbiomes as Sources of Postbiotic Therapeutics: A One Health Perspective on Translational Applications.","authors":"Victor Uchenna Chigozie, Eddison Igho Oghonyon, Emmanuel Okoro Enyi","doi":"10.1007/s12602-026-11293-3","DOIUrl":"https://doi.org/10.1007/s12602-026-11293-3","url":null,"abstract":"<p><p>Environmental microbiomes are reservoirs of specialized microorganisms with implications for ecosystem functionality, host health, and therapeutic discovery. Soil, marine, plant-associated, wastewater, freshwater, and extreme-environment microbiomes contain communities capable of producing bioactive metabolites and functional biomolecules. Postbiotics-non-viable microorganisms and their functional components that confer health benefits-offer potential advantages in stability, safety, scalability, and pharmaceutical development. This review examines environmental microbiomes as sources of postbiotic therapeutics within a One Health framework. A critical integrative translational review synthesized literature on environmental microbiomes, postbiotic diversity, molecular mechanisms, therapeutic applications, technological advances, and barriers to clinical translation. Evidence was organized across ecological sources, postbiotic classes, human-health applications, discovery platforms, pharmaceutical development, and translational challenges. Environmental microbiomes represent chemically and functionally diverse reservoirs of postbiotic candidates shaped by ecological adaptation, microbial competition, and environmental selection. Major classes-including short-chain fatty acids, bacteriocins, extracellular vesicles, indole and tryptophan metabolites, exopolysaccharides, and microbial/lytic enzymes-act through receptor signaling, immune modulation, barrier protection, antimicrobial activity, metabolic regulation, intercellular communication, and enzymatic target modification. Metagenomics, metabolomics, artificial intelligence, synthetic biology, organoid and microfluidic models, advanced delivery systems, and biomanufacturing increasingly enable discovery and development. However, reproducibility, microbiome variability, manufacturing scalability, regulatory standardization, cost, and equitable translation remain barriers. Environmental microbiomes provide important reservoirs for postbiotic discovery. Integrating ecological microbiology with multi-omics, computational innovation, pharmaceutical engineering, and human-relevant validation could accelerate development of defined, reproducible, and scalable postbiotic therapeutics. Preserving microbial ecosystem diversity is relevant to environmental sustainability and future microbiome-derived therapeutic innovation within One Health medicine.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altitudin S, an Antimicrobial Peptide Produced by Bacillus altitudinis ECC22, Defines a Novel Subgroup of Circular Bacteriocins. 由高原芽孢杆菌ECC22产生的抗菌肽Altitudin S定义了一个新的环状细菌素亚群。
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-12 DOI: 10.1007/s12602-026-11304-3
Ester Sevillano, Irene Lafuente, Nuria Peña, Cleopatra Collado, Luis M Cintas, Estefanía Muñoz-Atienza, Pablo E Hernández, Juan Borrero
{"title":"Altitudin S, an Antimicrobial Peptide Produced by Bacillus altitudinis ECC22, Defines a Novel Subgroup of Circular Bacteriocins.","authors":"Ester Sevillano, Irene Lafuente, Nuria Peña, Cleopatra Collado, Luis M Cintas, Estefanía Muñoz-Atienza, Pablo E Hernández, Juan Borrero","doi":"10.1007/s12602-026-11304-3","DOIUrl":"https://doi.org/10.1007/s12602-026-11304-3","url":null,"abstract":"<p><p>Bacteriocins are ribosomally synthesized antimicrobial peptides with diverse structures and mechanisms of action. Bacillus altitudinis ECC22, previously shown to produce the circular bacteriocins pumilarin and altitudin A, was found to harbor an additional biosynthetic gene cluster (BGC) encoding a novel circular bacteriocin, designated altitudin S. Proteomic analysis of purified active supernatant fractions confirmed the production of altitudin S, with a molecular mass of 8379.7 Da, while LC-MS/MS identification of a peptide spanning the N-to-C-terminal junction provided direct evidence of head-to-tail cyclization. Altitudin S is synthesized as a 132-residue precursor comprising a 56-amino-acid leader and a 76-residue circular mature core. Structural modeling predicted a compact saposin-like fold composed of five α-helices and a strongly cationic surface (pI ≈ 11.0, net charge + 13). Altitudin S was also produced using an in vitro cell-free protein synthesis system coupled with split-intein mediated ligation (IV-CFPS/SIML) and exhibited a narrow antimicrobial spectrum. Comprehensive sequence and phylogenetic analyses revealed that altitudin S is a highly divergent circular bacteriocin with distinctive sequence features and predicted physicochemical properties, including an exceptionally high isoelectric point, strong cationic charge, and low hydrophobicity. Homologs were identified across diverse Bacillales species, displaying high sequence similarity, conserved structural features, and a shared predicted physicochemical profile. Their BGCs were also highly conserved and consistently encoded an M48-family metallopeptidase. Collectively, these findings support the proposal of altitudin S and its homologs as representatives of a novel third subgroup (subgroup III) of circular bacteriocins.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Two Lactobacillus Strains on Aloe Vera-Induced Melanosis Coli in Guinea Pigs and Their Potential Mechanisms. 两株乳杆菌对芦荟诱导的豚鼠大肠黑变病的影响及其可能机制
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-12 DOI: 10.1007/s12602-026-11287-1
Danting Li, Lamei Zhou, Qi Wu, Yuxi Fang, Tiantian Wang, Lijuan Kang, Yinqing Li, Zhiqi Yin, Jian Zhang
{"title":"Effects of Two Lactobacillus Strains on Aloe Vera-Induced Melanosis Coli in Guinea Pigs and Their Potential Mechanisms.","authors":"Danting Li, Lamei Zhou, Qi Wu, Yuxi Fang, Tiantian Wang, Lijuan Kang, Yinqing Li, Zhiqi Yin, Jian Zhang","doi":"10.1007/s12602-026-11287-1","DOIUrl":"https://doi.org/10.1007/s12602-026-11287-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study primarily elucidated the efficacy of Lactobacillus plantarum P-8 (P8) and Lactobacillus acidophilus 85 (LA85) against melanosis coli (MC), a non-inflammatory bowel disease characterized by colonic mucosal lipofuscin deposition, currently lacking specific therapeutic interventions.</p><p><strong>Methods: </strong>The MC guinea pig model was established via 8-week intragastric administration of Aloe Vera (AV). Colonic tissues were harvested after 4 weeks of daily oral Lactobacillus gavage. Gross observation, H&E staining, and Fontana-Masson staining were employed to assess therapeutic efficacy. Western blotting and TUNEL staining were utilized to evaluate apoptosis of intestinal epithelial cells. Gut microbiota was analyzed by 16​S rRNA sequencing, and GC-MS was used to quantify short-chain fatty acid (SCFA) levels.</p><p><strong>Results: </strong>P8 and LA85 significantly alleviated MC in guinea pigs, with effective reduction in melanosis area, restoration of colonic tight junction protein expression, and inhibition of intestinal epithelial cell apoptosis. Additionally, P8 and LA85 supplementation ameliorated gut microbiota composition, exhibiting increased abundance of Parabacteroides and Rikenellaceae_RC9_gut_group with reduction in norank_f__Eubacteriaceae. Furthermore, P8 supplementation was associated with significant reductions in the fecal levels of acetic acid, propionic acid, butanoic acid, valeric acid, and isohexanoic acid, whereas LA85 did not significantly alter the measured SCFA levels.</p><p><strong>Conclusion: </strong>P8 and LA85 significantly alleviated MC with inhibition of intestinal epithelial cell apoptosis and modulation of gut microbiota composition. These findings provide a scientific basis for utilizing P8 and LA85 as potential nutritional supplements in MC treatment.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Biomimetic gut-on-a-chip Integrated with Multi-Omics Reveal the Mechanism of Listeria monocytogenes Infection Microenvironment-Stimulated In Situ Bacteriocin Production by Lactiplantibacillus paraplantarum RX-8. 集成多组学的仿生肠道芯片揭示单核增生李斯特菌感染微环境诱导副植物乳杆菌RX-8原位产菌素的机制
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-12 DOI: 10.1007/s12602-026-11300-7
Kaisheng Shen, Linyue Shi, Tianqi Guo, Wenyu Ma, Yanbo Wang, Guorong Liu
{"title":"A Biomimetic gut-on-a-chip Integrated with Multi-Omics Reveal the Mechanism of Listeria monocytogenes Infection Microenvironment-Stimulated In Situ Bacteriocin Production by Lactiplantibacillus paraplantarum RX-8.","authors":"Kaisheng Shen, Linyue Shi, Tianqi Guo, Wenyu Ma, Yanbo Wang, Guorong Liu","doi":"10.1007/s12602-026-11300-7","DOIUrl":"https://doi.org/10.1007/s12602-026-11300-7","url":null,"abstract":"<p><p>Bacteriocins produced in intestine by lactic acid bacteria (LAB) can suppress pathogens and support homeostasis, offering potential against foodborne bacterial infections. However, complex in vivo intestinal milieu hampers monitoring of bacteriocin production and its regulation during enteric infection. Herein, we developed and first applied a three-dimensional gut-on-a-chip with an intact mucus layer, robust barrier function, and stable immune homeostasis to dynamically examine bacteriocin biosynthesis during infection. Compared with its bacteriocin gene-deletion mutant, L. paraplantarum RX-8 reduced adherent L. monocytogenes by 2.69 lg CFU/mL, preserved mucin and tight-junction integrity, and suppressed pro-inflammatory cytokine release, highlighting the anti-infective role of in situ-produced plantaricin. Although infection modestly reduced L. paraplantarum RX-8 density, it reshaped plnA dynamics, enhanced plnBCD, plaRX, pfs, and luxS transcription, AI-2 activity, and plantaricin RX-8 production 2.25-fold, suggesting coordinated regulation by intraspecies PlnA and interspecies LuxS/AI-2 quorum-sensing (QS) systems. Integrated multi-omics analysis linked this QS-associated phenotype to metabolic, environmental-sensing, and transport reprogramming. Enhanced carbohydrate uptake, pyruvate oxidation, electron transport, and riboflavin metabolism may support ATP generation, redox homeostasis, and stress adaptation. Sulfur-containing amino acid metabolism may shift from de novo synthesis toward the activated methyl cycle and AI-2-associated processes, while altered two-component signaling, ABC transport, and SecYEG/YidC-associated export may enhance signal sensing, nutrient acquisition, and plantaricin biosynthesis and secretion. Finally, infection-responsive sRNA0019 was predicted to target plnA and luxS, suggesting a candidate post-transcriptional regulatory layer for both QS systems. These findings provide multilevel insights into bacteriocin biosynthesis during intestinal infection, supporting the efficient application of bacteriocin-producing LAB.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LC-QTOF/MS-based Mapping of Antioxidant and Antibacterial Peptides in the Water-soluble Extract of Postbiotic-supplemented White Cheese: In Silico and In Vitro Approaches. 基于LC-QTOF/ ms的白奶酪水溶性提取物中抗氧化和抗菌肽的定位:硅内和体外方法
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-11 DOI: 10.1007/s12602-026-11301-6
Yasemin Kaya, Mustafa Şengül, Hale İnci Öztürk, Enes Dertli
{"title":"LC-QTOF/MS-based Mapping of Antioxidant and Antibacterial Peptides in the Water-soluble Extract of Postbiotic-supplemented White Cheese: In Silico and In Vitro Approaches.","authors":"Yasemin Kaya, Mustafa Şengül, Hale İnci Öztürk, Enes Dertli","doi":"10.1007/s12602-026-11301-6","DOIUrl":"10.1007/s12602-026-11301-6","url":null,"abstract":"<p><p>This study examined water-soluble extracts (WSEs) obtained from white cheeses supplemented with 1% and 3% postbiotics derived from Liquorilactobacillus hordei SK-6 (A) and Lactiplantibacillus plantarum VB-29 (B) during 100 days of storage. The peptide profiles of the WSEs were characterized by LC-QTOF/MS, and the in silico antioxidant and antimicrobial potential of the identified peptides was evaluated. In addition, the in vitro antioxidant and antibacterial activities of the WSEs were determined. LC-QTOF/MS analysis revealed that β-casein (β-CN)-derived peptides predominated in WSEs obtained from control cheeses (C-WSEs), whereas α<sub>s1</sub>-casein (α<sub>s1</sub>-CN)-derived peptides predominated in WSEs obtained from postbiotic-supplemented cheeses (P-WSEs), indicating that peptide profiles differed depending on the postbiotic type. In silico analyses identified LLRF and LRF, which were detected in all P-WSEs, as candidate peptides with potential antioxidant and antibacterial activities. In the in vitro analyses, the 3% P-WSEs exhibited the highest antioxidant activity, with mean IC<sub>50</sub> values of 11.32 and 1.83 mg/mL for the DPPH and ABTS assays, respectively, and a FRAP value of 38.08 mg TE/100 g WSE. Furthermore, during storage, fluctuations in the antioxidant activity of the WSEs were observed, whereas antibacterial activity showed an overall decline toward Day 100. In contrast, antibacterial activity was highest in the 1% P-WSEs and lowest in the 3% P-WSEs. Overall, postbiotic supplementation affected the peptide profiles and biological activities of the WSEs, contributing to the identification of potentially bioactive peptides.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotic Pediococcus pentosaceus NQ0729 Attenuates ETEC-Induced Rumen Epithelial Injury in Yak Calves. 益生菌戊糖Pediococcus petosaceus NQ0729减轻etec诱导的牦牛犊牛瘤胃上皮损伤
IF 5.3 2区 生物学
Probiotics and Antimicrobial Proteins Pub Date : 2026-11-10 DOI: 10.1007/s12602-026-11266-6
Yanbin Zhu, Bingang Shi, Shaobin Li, Yangji Cidan, Jiang Hu, Wangdui Basang
{"title":"Probiotic Pediococcus pentosaceus NQ0729 Attenuates ETEC-Induced Rumen Epithelial Injury in Yak Calves.","authors":"Yanbin Zhu, Bingang Shi, Shaobin Li, Yangji Cidan, Jiang Hu, Wangdui Basang","doi":"10.1007/s12602-026-11266-6","DOIUrl":"https://doi.org/10.1007/s12602-026-11266-6","url":null,"abstract":"<p><p>Enterotoxigenic Escherichia coli (ETEC) infection is an important cause of gastrointestinal injury in young animals. However, whether probiotic strains isolated from naturally fermented yak yogurt can protect rumen epithelial health in ETEC-challenged yak calves remains unclear. This study investigated the effects of Pediococcus pentosaceus NQ0729 isolated from naturally fermented yak yogurt on ETEC-induced rumen epithelial injury and explored its associations with the rumen microbiota and microbiota-associated metabolites. ETEC challenge increased the serum IL-1β, IL-6, TNF-α, IFN-γ, MDA, and ROS levels and decreased the IL-10, SOD, CAT, GSH-Px, and T-AOC levels (P < 0.05). P. pentosaceus NQ0729 pretreatment attenuated these inflammatory and oxidative stress responses (P < 0.05). ETEC challenge also caused rumen epithelial morphological damage, increased epithelial apoptosis, and reduced the expression of epithelial barrier-related markers, including ZO-1, Occludin, and Claudin-4, as well as the mucin-related marker MUC2 (P < 0.05). These alterations were partially attenuated by P. pentosaceus NQ0729 pretreatment (P < 0.05). In addition, P. pentosaceus NQ0729 reduced the activation of TLR4/MyD88/NF-κB-related inflammatory signaling and enhanced Nrf2-associated antioxidant defense in rumen tissues (P < 0.05). 16 S rRNA gene sequencing and untargeted metabolomics revealed that P. pentosaceus NQ0729 altered the rumen microbial composition and ruminal metabolite profile. Integrated analysis further revealed significant associations among differential rumen genera, microbiota-associated metabolites, and host inflammatory, oxidative stress, antioxidant, and barrier-related indices (P < 0.05). P. pentosaceus NQ0729 alleviated ETEC-induced rumen epithelial injury in yak calves, which was accompanied by reduced inflammation and oxidative stress, improved epithelial barrier-related markers, and changes in the rumen microbiota and microbiota-associated metabolites. These findings suggest that P. pentosaceus NQ0729 may protect rumen epithelial homeostasis, with its protective effects accompanied by changes in the rumen microbiota and microbiota-associated metabolites and by significant associations among microbial, metabolic, and host barrier-related features.</p>","PeriodicalId":20506,"journal":{"name":"Probiotics and Antimicrobial Proteins","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书